Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lorcaserin Makes It Past Panel On The Strength Of Effect In Some Patients

May 14 2012

• By Cathy Dombrowski

Related Content

Weighty Issues: GW Obesity Outcomes Project Tests Model For Patient Input In Drug Development

May 14 2012

Lorcaserin Advisory Committee Will Again Be Weighed Down By Safety Concerns

May 08 2012

Lorcaserin Safety Questions Can Be Answered In Post-Market Study, Panel Tells FDA

May 11 2012

Arena Must Deal With Rat Neoplasms To Move Forward With <i>Lorqess</i>

Sep 20 2010

Related Companies

Arena Pharmaceuticals, Inc.

Vivus, Inc.

Orexigen Therapeutics, Inc.

Additional Topics

Advisory Committees BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window